Our staff is here to support the community during these difficult times. We are safely and effectively communicating with clients by phone, email and video conference. Contact Us Today!

Invokana’s Cardiovascular Risks: What You Need to Know

Earlier this year, the FDA approved Invokana to reduce late-stage kidney disease and improve cardiovascular health in patients living with Type 2 diabetes and diabetic kidney disease. However, lawsuits dating back to 2015 indicate adverse cardiovascular events like heart attacks may be a side effect for certain patients.

Read More

Is Opioid Use a Factor in Car Accident Fatality Rates?

A study from the National Safety Council indicates that more Americans die from opioids than car accidents. However, recent research indicates opioid usage may influence car fatality rates, particularly as drunk driving accidents have been on a gradual decline over the past 20 years.

Read More

The FDA Approves Label Change for Diabetes Drugs

The US Food and Drug Administration (FDA) recently approved a safety label change for a class of type 2 diabetes medicines called sodium-glucose transporter 2 (SGLT2) inhibitors. These drugs may lead to an increased risk of diabetic ketoacidosis, blood, kidney and serious urinary tract infections.

Read More

Purdue Pharma Opioid Settlement: What You Should Know

In September 2019, Purdue Pharma reached an agreement to settle the large number of pending claims against their company. Purdue and its subsidiaries decided to file for Chapter 11 bankruptcy, which will help restructure the company, remove the company’s founding family and restrict where and how Purdue Pharma can do business moving forward.

Read More

What Role Did Pharmacies Play in the Opioid Epidemic?

Since 2000, the opioid epidemic has claimed the lives of more than 400,000 Americans. Drug company marketing campaigns and the practices of the Drug Enforcement Administration (DEA) are responsible for over 100 related deaths per day.

Read More